Terrein performs antitumor functions on esophageal cancer cells by inhibiting cell proliferation and synergistic interaction with cisplatin

Wu,Yanqing; Zhu,Yinghua; Li,Shunrong; Zeng,Minhua; Chu,Junjun; Hu,Pengnan; Li,Jingjing; Guo,Qiannan; Lv,Xiao‑Bin; Huang,Guofu

doi:10.3892/ol.2017.5758

Terrein performs antitumor functions on esophageal cancer cells by inhibiting cell proliferation and synergistic interaction with cisplatin

Authors:
- Yanqing Wu
- Yinghua Zhu
- Shunrong Li
- Minhua Zeng
- Junjun Chu
- Pengnan Hu
- Jingjing Li
- Qiannan Guo
- Xiao‑Bin Lv
- Guofu Huang
View Affiliations

Affiliations: Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Sun Yat‑Sen University, Guangzhou, Guangdong 510700, P.R. China, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat‑Sen Memorial Hospital affiliated to Sun Yat‑Sen University, Guangzhou, Guangdong 51012, P.R. China, Nanchang Key Laboratory of Cancer Pathogenesis and Translational Research, Center Laboratory, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330008, P.R. China, Department of Ophthalmology, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330008, P.R. China
Published online on: February 22, 2017 https://doi.org/10.3892/ol.2017.5758
Pages: 2805-2810

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Terrein is a bioactive fungal metabolite isolated from Aspergillus terreus. Besides being a melanogenesis inhibitor, previous studies have revealed that terrein has antiproliferative effects on a number of types of cancer tumors. In the present study, the inhibitory effect of terrein on esophageal cancer was evaluated and the possible underlying mechanisms were investigated. The results revealed that terrein inhibited the proliferation of Eca109 esophageal cancer cells in a dose‑ and time‑dependent manner. Mechanistically, terrein treatment led to the G2/M phase arrest of Eca109 cells by indirectly regulating cyclin B1 and phosphorylating the cell division cycle protein 2 genes. Notably, terrein exhibited a synergistic effect on Eca109 cells when combined with cisplatin, which is a commonly used chemotherapeutic drug. Taken together, these findings indicate that terrein suppresses the proliferation of esophageal cancer cells, and may prove to be a novel therapeutic approach for the treatment of esophageal cancer via inhibiting the proliferation of cancer cells.